ALS Association DONATE | CONTACT US | HOME
 SEARCH
The ALS Association Northern New England Chapter
About ALS About Our Chapter Events How You Can Help Donate
In The News Patient and Family Services Public Policy Research

Helping Hands
Compassion for Clunkers 

Donate your used car to help support research to find a cure for ALS and provide much-needed services to patients and their families in Maine, New Hampshire,and Vermont.
Click here to learn more!

Events
Please click here to view 2009 Walk to Defeat ALSTM Photos

March 13th, 2010 - Carl Johnson Memorial Ski-A-Thon

Walk to Defeat ALSTM

Saturday, August 28th, 2010
Hayford Park, Bangor ME

Saturday, September 11th, 2010
Payson Park, Portland ME

Sunday, September 26, 2010
Dorset Park, Burlington VT

Saturday, October 2, 2010
State House Plaza, Concord NH


News

  • Research Updates
  • Advocacy Updates
  • ALS in the News


    Patients
  • Support Groups
  • Patient & Family Services
  • Facts About Family Caregivers
  • Vehicle and Equipment Exchange
  • Commonly Asked Questions
  • Poems & Stories
  • Publications & Videos


    Quick Links
  • Workplace Giving
  • Opportunities to Serve in a Leadership Role
  • ALS & the Military

  • Stay Connected
                                                                                                                                                                                                                                                       />                                                                                                                                                                                                                                            /> Youtube


    Community Health Charities - Maine

    _____________________________

     

     

    Spotlight Bar 9_07 

    First ALS Patient Receives Isis-SOD1RX
    Antisense Treatment in Phase 1 Clinical Trial

    Isis Pharmaceuticals, Inc. has initiated a Phase 1 study of ISIS-SOD1Rx in patients with an inherited, aggressive form of Lou Gehrig’s disease also known as familial amyotrophic lateral sclerosis (ALS).  Approximately 20 percent of all familial ALS cases are caused by a mutant form of superoxide dismutase, or SOD1.  The ALS Association and the Muscular Dystrophy Association are providing funding for the development of ISIS-SOD1Rx.

    ISIS-SOD1Rx is an antisense drug designed to inhibit the production of SOD1.  Antisense techniques are used to deactivate disease-causing or undesirable genes so that they cannot produce harmful or unwanted proteins.

    "This therapy will be the first treatment for ALS that is specifically aimed at the target, SOD1, known to cause ALS. The development of new treatments for ALS is an extremely challenging and costly process.  The ALS Association has been pleased to co-fund this study and partner with Isis on this extremely promising treatment approach. It is only through the support of our generous donors that this type of advancement is made possible," commented Lucie Bruijn, Ph.D., Chief Scientist, The ALS Association.

     

    Read full story


    Spotlight Top

    Spotlight Page Wrapper Image

    Walk to Defeat ALS

    Walk 

because you can...
    because you can...

    Join Us! >>

    Community of Hope

    Tribute Funds to Honor and Remember.

    Community of Hope
    Find or Create a Fund>>
    Donate Now

    Make a general gift
    to our chapter.
    Your donation supports
    The ALS Association's mission.

    Donate Now >>

    eNewsletter

      Sign up for our Monthly eNewsletter "Connections"

    *

    *

     

    If you respond and have not already registered, you will receive periodic updates and communications from The ALS Association.

     

    What's this?

       Please leave this field empty
    Printer Friendly Version 
    BBB  NHC 

     


      Powered By Convio